Metastatic adenocarcinoma in the parotid gland in a horse – clinical and pathological findings.

This case report describes a rare, aggressive salivary gland cancer in a horse that spread through lymphatic pathways; despite surgical removal of the parotid gland, the horse died from hypovolemic shock shortly after anesthesia recovery. Necropsy confirmed metastasis to regional lymph nodes and lymphatic vessels near the thoracic inlet, underscoring poor prognosis and the need for earlier diagnosis and better therapies.

What the case report studied and why it matters

• Describes a metastatic adenocarcinoma originating in the parotid salivary gland of a horse—a neoplasm considered uncommon in equids and associated with limited, often ineffective, treatment options.
• Highlights the aggressive biological behavior, early lymphatic spread, and poor clinical outcomes, emphasizing the importance of timely recognition and comprehensive staging.

Patient and initial presentation

• Species/breed/age/sex: 12-year-old Criollo gelding.
• Primary complaint: Progressive enlargement of the left parotid gland, persisting for approximately 6 months without response to prior treatments.
• Clinical context: Chronic, treatment-refractory enlargement raises concern for neoplasia in addition to inflammatory or obstructive causes (for example, sialadenitis, sialolithiasis, abscess, or granulomatous disease).

Diagnostic work-up and decision-making

• Diagnostic procedures (not fully detailed in the abstract) informed the decision to proceed with total sialadenectomy, indicating a presumptive or confirmed malignant salivary tumor.
• Definitive diagnosis of salivary adenocarcinoma typically relies on cytology/histopathology; staging commonly includes assessment of regional lymph nodes and thoracic structures given lymphatic routes of spread.
• Involvement of the parotid region necessitates careful evaluation because of the proximity to major vessels and nerves, which influences surgical risk and feasibility.

Treatment and perioperative course

• Intervention: Total sialadenectomy of the affected parotid gland was performed.
• Outcome: The horse died of hypovolemic shock in the recovery room following anesthesia, consistent with catastrophic hemorrhage or severe intravascular volume loss—a known risk in this highly vascular anatomical region.
• Technical challenges: The parotid area contains critical vasculature and the facial nerve, complicating dissection and hemostasis; extensive tumor infiltration can increase operative difficulty and blood loss.

Post-mortem findings and tumor behavior

• Necropsy revealed metastatic neoplastic infiltration of the submandibular lymph nodes.
• Neoplastic cells also infiltrated the lymphatic network at the entrance to the thorax (thoracic inlet), indicating advanced lymphatic dissemination beyond the primary site.
• Interpretation: The pattern is consistent with salivary adenocarcinoma spreading via regional lymphatics, explaining the poor response to prior treatments and the guarded-to-poor prognosis.

Clinical implications and prognosis

• Biologic aggressiveness: Early lymphatic metastasis and regional infiltration reduce the likelihood that surgery alone can be curative.
• Prognosis: Poor once nodal or thoracic lymphatic involvement is present; even with aggressive surgery, survival benefit is uncertain and perioperative risks are substantial.
• Therapeutic landscape: Equine-specific protocols for adjunctive radiotherapy or chemotherapy are limited in availability, evidence, and practicality, constraining options beyond palliative care.

Recommendations for practice

• Early recognition: Consider neoplasia in any chronic, nonresponsive parotid enlargement; prioritize timely tissue diagnosis (fine-needle aspiration or biopsy) over prolonged empirical therapy.
• Comprehensive staging: Evaluate regional lymph nodes and thoracic structures to inform prognosis and guide decision-making before major surgery.
• Risk counseling: Discuss substantial intra- and postoperative hemorrhage risks and the potential for limited benefit from surgery when advanced metastasis is suspected.
• Care goals: When disease is metastatic, emphasize welfare-oriented management, pain control, and owner-informed decisions regarding the balance of risks and expected outcomes.

Strengths, limitations, and generalizability

• Strength: Adds detailed clinical and pathological documentation of a rare equine salivary gland malignancy with confirmed metastatic spread.
• Limitations: Single-case design limits generalizability; the abstract provides limited detail on imaging, histologic grading, and any attempted adjunctive therapies, precluding conclusions about comparative effectiveness.
• Implication: While illustrative, broader datasets are needed to define optimal diagnostic pathways and evaluate multimodal treatments in horses.

Key takeaways

• Metastatic parotid adenocarcinoma in horses is rare but highly aggressive, often spreading early via lymphatics.
• Prolonged, ineffective treatment of parotid enlargement should trigger prompt biopsy and staging.
• Surgical excision may be technically challenging and not curative in metastatic disease; prognosis is poor, underscoring the need for earlier diagnosis and exploration of more effective therapies.